Rio Dumitrascu

2.9k total citations
32 papers, 2.0k citations indexed

About

Rio Dumitrascu is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Molecular Biology. According to data from OpenAlex, Rio Dumitrascu has authored 32 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pulmonary and Respiratory Medicine, 9 papers in Physiology and 8 papers in Molecular Biology. Recurrent topics in Rio Dumitrascu's work include Pulmonary Hypertension Research and Treatments (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Neonatal Respiratory Health Research (5 papers). Rio Dumitrascu is often cited by papers focused on Pulmonary Hypertension Research and Treatments (15 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Neonatal Respiratory Health Research (5 papers). Rio Dumitrascu collaborates with scholars based in Germany, United Kingdom and Belgium. Rio Dumitrascu's co-authors include Werner Seeger, Ralph T. Schermuly, Norbert Weißmann, Friedrich Grimminger, Hossein Ardeschir Ghofrani, Soni Savai Pullamsetti, Richard Schulz, Oliver Eickelberg, Mélanie Königshoff and Eva Dony and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Rio Dumitrascu

30 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rio Dumitrascu Germany 24 1.2k 626 590 570 211 32 2.0k
C.H.C. Twort United Kingdom 23 599 0.5× 564 0.9× 969 1.6× 228 0.4× 119 0.6× 43 1.8k
Jan Herget Czechia 23 840 0.7× 431 0.7× 593 1.0× 446 0.8× 193 0.9× 91 1.8k
Alexander Paliege Germany 23 489 0.4× 1.1k 1.7× 319 0.5× 318 0.6× 201 1.0× 54 2.2k
Nicolas Picard France 25 547 0.4× 1.4k 2.2× 231 0.4× 356 0.6× 197 0.9× 52 2.3k
Kerry J. Rhoden Italy 25 405 0.3× 686 1.1× 494 0.8× 105 0.2× 297 1.4× 49 2.0k
May Bloch-Faure France 22 376 0.3× 1.1k 1.7× 383 0.6× 630 1.1× 132 0.6× 29 2.1k
Naoki Isaka Japan 28 394 0.3× 1.2k 2.0× 499 0.8× 1.1k 1.9× 379 1.8× 87 2.9k
Narihito Seki Japan 31 803 0.6× 654 1.0× 257 0.4× 143 0.3× 464 2.2× 134 3.4k
RA Panettieri United States 17 362 0.3× 1.2k 1.9× 837 1.4× 164 0.3× 159 0.8× 22 2.2k
Risa Korenaga Japan 21 229 0.2× 881 1.4× 587 1.0× 411 0.7× 342 1.6× 25 2.1k

Countries citing papers authored by Rio Dumitrascu

Since Specialization
Citations

This map shows the geographic impact of Rio Dumitrascu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rio Dumitrascu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rio Dumitrascu more than expected).

Fields of papers citing papers by Rio Dumitrascu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rio Dumitrascu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rio Dumitrascu. The network helps show where Rio Dumitrascu may publish in the future.

Co-authorship network of co-authors of Rio Dumitrascu

This figure shows the co-authorship network connecting the top 25 collaborators of Rio Dumitrascu. A scholar is included among the top collaborators of Rio Dumitrascu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rio Dumitrascu. Rio Dumitrascu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dumitrascu, Rio, Rajkumar Savai, Andreas Braeuninger, et al.. (2023). Case Report: Durable therapy response to Osimertinib in rare EGFR Exon 18 mutated NSCLC. Frontiers in Oncology. 13. 1182391–1182391.
2.
Uhl, Eberhard, et al.. (2022). Palliative care of older glioblastoma patients in neurosurgery. Journal of Neuro-Oncology. 157(2). 297–305. 5 indexed citations
3.
Dumitrascu, Rio, et al.. (2022). Outpatient palliative care during the COVID-19 pandemic: a retrospective single centre analysis in Germany. BMC Palliative Care. 21(1). 144–144.
4.
Tiede, Henning, Rio Dumitrascu, Frank Reichenberger, et al.. (2015). Poor sleep quality is associated with exercise limitation in precapillary pulmonary hypertension. BMC Pulmonary Medicine. 15(1). 11–11. 12 indexed citations
5.
Dumitrascu, Rio, Henning Tiede, Konstantin Mayer, et al.. (2013). Sleep apnea in precapillary pulmonary hypertension. Sleep Medicine. 14(3). 247–251. 59 indexed citations
6.
Arzt, Michael, et al.. (2012). Sleep-disordered breathing in deep vein thrombosis and acute pulmonary embolism. European Respiratory Journal. 40(4). 919–924. 48 indexed citations
7.
Kneidinger, Nikolaus, Ali Önder Yildirim, Jens Callegari, et al.. (2010). Activation of the WNT/β-Catenin Pathway Attenuates Experimental Emphysema. American Journal of Respiratory and Critical Care Medicine. 183(6). 723–733. 149 indexed citations
8.
Schermuly, Ralph T., Rio Dumitrascu, Norbert Weißmann, et al.. (2010). Treprostinil inhibits the recruitment of bone marrow-derived circulating fibrocytes in chronic hypoxic pulmonary hypertension. European Respiratory Journal. 36(6). 1302–1314. 32 indexed citations
9.
Dumitrascu, Rio, Soni Savai Pullamsetti, Hamza M. Al-tamari, et al.. (2010). Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice. BMC Pulmonary Medicine. 10(1). 26–26. 37 indexed citations
10.
Wempe, Frank, Katri Koli, Thorsten Bangsow, et al.. (2010). Inactivation of sestrin 2 induces TGF-β signaling and partially rescues pulmonary emphysema in a mouse model of COPD. Disease Models & Mechanisms. 3(3-4). 246–253. 42 indexed citations
11.
Dumitrascu, Rio, Mélanie Königshoff, Fotini M. Kouri, et al.. (2010). Terguride ameliorates monocrotaline-induced pulmonary hypertension in rats. European Respiratory Journal. 37(5). 1104–1118. 73 indexed citations
12.
Königshoff, Mélanie, Rio Dumitrascu, Oana V. Amarie, et al.. (2010). Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention. Thorax. 65(11). 949–955. 64 indexed citations
13.
Dahal, Bhola K., Aleksandra Tretyn, Soni Savai Pullamsetti, et al.. (2009). Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 181(2). 158–167. 105 indexed citations
14.
Weißmann, Norbert, Bhola K. Dahal, Soni Savai Pullamsetti, et al.. (2009). The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice. American Journal of Physiology-Lung Cellular and Molecular Physiology. 297(4). L658–L665. 31 indexed citations
15.
Savai, Rajkumar, Alexander C. Langheinrich, Ralph T. Schermuly, et al.. (2009). Evaluation of Angiogenesis Using Micro-Computed Tomography in a Xenograft Mouse Model of Lung Cancer. Neoplasia. 11(1). 48–56. 80 indexed citations
16.
Dumitrascu, Rio, Eva Dony, Norbert Weißmann, et al.. (2008). Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury. BMC Pulmonary Medicine. 8(1). 25–25. 33 indexed citations
17.
Schermuly, Ralph T., J.-P. Stasch, Soni Savai Pullamsetti, et al.. (2008). Expression and function of soluble guanylate cyclase in pulmonary arterial hypertension. European Respiratory Journal. 32(4). 881–891. 188 indexed citations
18.
Nguyen, Juliane, Xiulan Xie, Michael Neu, et al.. (2008). Effects of cell‐penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs. The Journal of Gene Medicine. 10(11). 1236–1246. 71 indexed citations
19.
Dony, Eva, Ying‐Ju Lai, Rio Dumitrascu, et al.. (2007). Partial reversal of experimental pulmonary hypertension by phosphodiesterase-3/4 inhibition. European Respiratory Journal. 31(3). 599–610. 27 indexed citations
20.
Schermuly, Ralph T., Hüseyin Yılmaz, Hossein Ardeschir Ghofrani, et al.. (2005). Inhaled Iloprost Reverses Vascular Remodeling in Chronic Experimental Pulmonary Hypertension. American Journal of Respiratory and Critical Care Medicine. 172(3). 358–363. 54 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026